Acute kidney injury screening: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Acute kidney injury}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the...")
 
Line 15: Line 15:
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
==Screening==
==Screening==
There is insufficient evidence to recommend routine screening for [disease/malignancy].
Several laboratory tests are useful for screening of acute kidney injury among patients with risk factors as following:
 
*BUN
OR
*Creatinine
 
*Urine analysis
According to the [guideline name], screening for [disease name] is not recommended.
Electronic health record-based predictive models for acute kidney injury screening among pediatric inpatients, children aged 28 days through 21 years, with sufficient serum creatinine measurements are assessed by followings:<ref name="MalhotraKashani2017">{{cite journal|last1=Malhotra|first1=Rakesh|last2=Kashani|first2=Kianoush B.|last3=Macedo|first3=Etienne|last4=Kim|first4=Jihoon|last5=Bouchard|first5=Josee|last6=Wynn|first6=Susan|last7=Li|first7=Guangxi|last8=Ohno-Machado|first8=Lucila|last9=Mehta|first9=Ravindra|title=A risk prediction score for acute kidney injury in the intensive care unit|journal=Nephrology Dialysis Transplantation|volume=32|issue=5|year=2017|pages=814–822|issn=0931-0509|doi=10.1093/ndt/gfx026}}</ref><ref name="pmid18922990">{{cite journal |vauthors=Wu I, Parikh CR |title=Screening for kidney diseases: older measures versus novel biomarkers |journal=Clin J Am Soc Nephrol |volume=3 |issue=6 |pages=1895–901 |date=November 2008 |pmid=18922990 |doi=10.2215/CJN.02030408 |url=}}</ref>
 
*Age
OR
*Medication exposures
 
*Platelet count
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
*Red blood cell distribution width
*[Condition 1]
*Serum phosphorus
*[Condition 2]
*Serum transaminases
*[Condition 3]
*Hypotension (in ICU patients only)
*PH (in ICU patients only)


==References==
==References==

Revision as of 14:21, 29 June 2018

Acute kidney injury Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute Kidney Injury from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute kidney injury screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute kidney injury screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute kidney injury screening

CDC on Acute kidney injury screening

Acute kidney injury screening in the news

Blogs on Acute kidney injury screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Acute kidney injury screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

Several laboratory tests are useful for screening of acute kidney injury among patients with risk factors as following:

  • BUN
  • Creatinine
  • Urine analysis

Electronic health record-based predictive models for acute kidney injury screening among pediatric inpatients, children aged 28 days through 21 years, with sufficient serum creatinine measurements are assessed by followings:[1][2]

  • Age
  • Medication exposures
  • Platelet count
  • Red blood cell distribution width
  • Serum phosphorus
  • Serum transaminases
  • Hypotension (in ICU patients only)
  • PH (in ICU patients only)

References

  1. Malhotra, Rakesh; Kashani, Kianoush B.; Macedo, Etienne; Kim, Jihoon; Bouchard, Josee; Wynn, Susan; Li, Guangxi; Ohno-Machado, Lucila; Mehta, Ravindra (2017). "A risk prediction score for acute kidney injury in the intensive care unit". Nephrology Dialysis Transplantation. 32 (5): 814–822. doi:10.1093/ndt/gfx026. ISSN 0931-0509.
  2. Wu I, Parikh CR (November 2008). "Screening for kidney diseases: older measures versus novel biomarkers". Clin J Am Soc Nephrol. 3 (6): 1895–901. doi:10.2215/CJN.02030408. PMID 18922990.

Template:WH Template:WS